Pancreatobiliary Carcinoma — Trials

Pancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,131 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 699
Recruiting: 403
Ph III recruiting: 36
Growth YoY: +23.4%
Industry share: 30%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (303)

clinicaltrialsPublishedShowing 101–108 of 108 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00864513	Study of Pemetrexed for Second-Line Pancreas Cancer	terminated	Phase 2	17	Georgetown UniversityOTHER	1	Dec 8, 2015	clinicaltrials
NCT01227018	PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer	terminated	Phase 2	15	Vanderbilt-Ingram Cancer CenterOTHER	1	Jul 23, 2014	clinicaltrials
NCT00023946